Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Multiple Sclerosis

  Free Subscription


11.02.2019

2 Acta Neurol Scand
1 Ann Neurol
1 Brain
1 Epidemiology
2 J Neurol
2 J Neurol Sci
4 Mult Scler
1 Nat Rev Neurol
1 PLoS Genet
3 Proc Natl Acad Sci U S A
2 Rev Neurol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Neurol Scand

  1. DE BERNARDO M, Vitiello L, Rosa N
    Optic nerve ultrasound measurement in multiple sclerosis.
    Acta Neurol Scand. 2019 Feb 5. doi: 10.1111/ane.13072.
    PubMed     Text format     Abstract available

  2. CANDELIERE MERLICCO A, Gabaldon Torres L, Villaverde Gonzalez R, Fernandez Romero I, et al
    Response to: Comment on "Transorbital ultrasonography for measuring optic nerve atrophy in multiple sclerosis".
    Acta Neurol Scand. 2019 Feb 5. doi: 10.1111/ane.13076.
    PubMed     Text format     Abstract available


    Ann Neurol

  3. FADDA G, Brown RA, Magliozzi R, Aubert-Broche B, et al
    A surface-in gradient of thalamic damage evolves in pediatric multiple sclerosis.
    Ann Neurol. 2019 Feb 4. doi: 10.1002/ana.25429.
    PubMed     Text format     Abstract available


    Brain

  4. EDEN D, Gros C, Badji A, Dupont SM, et al
    Spatial distribution of multiple sclerosis lesions in the cervical spinal cord.
    Brain. 2019 Jan 30. pii: 5304670. doi: 10.1093.
    PubMed     Text format     Abstract available


    Epidemiology

  5. ALPING P, Piehl F, Langer-Gould A, Frisell T, et al
    Validation of the Swedish Multiple Sclerosis Register: Further Improving a Resource for Pharmacoepidemiologic Evaluations.
    Epidemiology. 2019;30:230-233.
    PubMed     Text format     Abstract available


    J Neurol

  6. GAMRAOUI S, Mathey G, Debouverie M, Malaplate C, et al
    High performance of cerebrospinal fluid immunoglobulin G analysis for diagnosis of multiple sclerosis.
    J Neurol. 2019 Feb 1. pii: 10.1007/s00415-019-09212.
    PubMed     Text format     Abstract available

  7. LEBRUN-FRENAY C, Moulignier A, Pierrot-Deseilligny C, Benrabah R, et al
    Five-year outcome in the copaxone observatory: a nationwide cohort of patients with multiple sclerosis starting treatment with glatiramer acetate in France.
    J Neurol. 2019 Feb 7. pii: 10.1007/s00415-019-09211.
    PubMed     Text format     Abstract available


    J Neurol Sci

  8. BEH SC
    The "eye of the tiger" in a patient with multiple sclerosis.
    J Neurol Sci. 2019;399:1-2.
    PubMed     Text format    

  9. FOX E, Vieira MC, Johnson K, Peeples M, et al
    Real-world durability of relapse rate reduction in patients with multiple sclerosis receiving fingolimod for up to 3years: a retrospective US claims database analysis.
    J Neurol Sci. 2019;398:163-170.
    PubMed     Text format     Abstract available


    Mult Scler

  10. NICOLETTI CG, Monteleone F, Marfia GA, Usiello A, et al
    Oral D-Aspartate enhances synaptic plasticity reserve in progressive multiple sclerosis.
    Mult Scler. 2019 Feb 7:1352458519828294. doi: 10.1177/1352458519828294.
    PubMed     Text format     Abstract available

  11. PLANCHE V, Su JH, Mournet S, Saranathan M, et al
    White-matter-nulled MPRAGE at 7T reveals thalamic lesions and atrophy of specific thalamic nuclei in multiple sclerosis.
    Mult Scler. 2019 Feb 7:1352458519828297. doi: 10.1177/1352458519828297.
    PubMed     Text format     Abstract available

  12. LEFEUVRE JA, Guy JR, Luciano NJ, Ha SK, et al
    The spectrum of spinal cord lesions in a primate model of multiple sclerosis.
    Mult Scler. 2019 Feb 7:1352458518822408. doi: 10.1177/1352458518822408.
    PubMed     Text format     Abstract available

  13. RAIMO S, Spitaleri D, Trojano L, Santangelo G, et al
    Apathy as a herald of cognitive changes in multiple sclerosis: A 2-year follow-up study.
    Mult Scler. 2019 Feb 7:1352458519828296. doi: 10.1177/1352458519828296.
    PubMed     Text format     Abstract available


    Nat Rev Neurol

  14. KELSEY R
    Prolonging the integrated stress response could be beneficial in multiple sclerosis.
    Nat Rev Neurol. 2019 Feb 4. pii: 10.1038/s41582-019-0142.
    PubMed     Text format    


    PLoS Genet

  15. HECKER M, Boxberger N, Illner N, Fitzner B, et al
    A genetic variant associated with multiple sclerosis inversely affects the expression of CD58 and microRNA-548ac from the same gene.
    PLoS Genet. 2019;15:e1007961.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  16. ZAHEDNASAB H, Keyvani H, Karampour S, Harirchian MH, et al
    Role of HHV-6 subtypes in accelerating EAE progression.
    Proc Natl Acad Sci U S A. 2018;115:E12126.
    PubMed     Text format    

  17. LEIBOVITCH EC, Jacobson S
    Reply to Zahednasab et al.: HHV-6 and marmoset EAE.
    Proc Natl Acad Sci U S A. 2018;115:E12127.
    PubMed     Text format    

  18. DUNCAN ID, Radcliff AB, Heidari M, Kidd G, et al
    The adult oligodendrocyte can participate in remyelination.
    Proc Natl Acad Sci U S A. 2018;115:E11807-E11816.
    PubMed     Text format     Abstract available


    Rev Neurol

  19. FERNANDEZ O, Tintore M, Saiz A, Calles-Hernandez MC, et al
    [Review of the novelties from the 2017 ECTRIMS Congress, presented at the 10th Post-ECTRIMS Meeting (II)].
    Rev Neurol. 2018;67:50-62.
    PubMed     Text format     Abstract available

  20. FERNANDEZ O, Tintore M, Saiz A, Calles-Hernandez MC, et al
    [Review of the novelties from the 2017 ECTRIMS Congress, presented at the 10th Post-ECTRIMS Meeting (I)].
    Rev Neurol. 2018;67:15-27.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: